Chinese First-In-Class Endeavors See Triumphs, Setbacks In Early 2025

 
• By Dexter Jie Yan
  
Early 2025 recorded two successes and two setbacks for Chinese first-moving drugs and candidates. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia